Epidemiologic Signatures in Cancer.

Interpreting Cancer Mortality The authors use 40 years of data on cancer incidence and mortality to produce curves that show changes in cancer incidence (decreasing, increasing, or staying stable) ...

[1]  D. Owens,et al.  Annual Report to the Nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics , 2018, Cancer.

[2]  W J Macdonald,et al.  GASTRIC CARCINOMA. , 1912, Canadian Medical Association journal.

[3]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[4]  L. Abenhaim.  [Progress against cancer!]. , 2003, Revue d'epidemiologie et de sante publique.

[5]  T. Holford,et al.  Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012 , 2014 .

[6]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[7]  C. Simone,et al.  Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer. , 2014, Clinical lung cancer.

[8]  A. Proudfoot,et al.  CANCER OF THE UTERINE CERVIX , 1957, The Ulster Medical Journal.

[9]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[10]  T. Holford,et al.  Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. , 2014, JAMA.

[11]  A. Bleyer,et al.  Effect of three decades of screening mammography on breast-cancer incidence. , 2012, The New England journal of medicine.

[12]  H. Welch,et al.  Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.

[13]  J. Elmore,et al.  Projecting the benefits and harms of mammography using statistical models: proof or proofiness? , 2015, Journal of the National Cancer Institute.

[14]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[15]  Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. , 2005, Journal of the American Medical Association.

[16]  R. Doll,et al.  Smoking and carcinoma of the lung; preliminary report. , 1950, British medical journal.

[17]  R. Blanks,et al.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.

[18]  Marvin Zelen,et al.  Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.

[19]  Steven Woloshin,et al.  When do changes in cancer survival mean progress? The insight from population incidence and mortality. , 2014, Journal of the National Cancer Institute. Monographs.

[20]  P. Prorok,et al.  Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. , 2016, The New England journal of medicine.

[21]  R. Richmond.  You've come a long way baby: Women and the tobacco epidemic. , 2003, Addiction.

[22]  H. Welch,et al.  Colorectal Cancer on the Decline--Why Screening Can't Explain It All. , 2016, The New England journal of medicine.

[23]  B. Kramer,et al.  Analysis of the role of cancer prevention and control measures in reducing cancer mortality. , 1991, Journal of the National Cancer Institute.

[24]  D. Longo.  Imatinib Changed Everything. , 2017, The New England journal of medicine.

[25]  W. Zahradka.  [Historical development of cause of death statistics]. , 1988, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete.

[26]  J C Bailar,et al.  Cancer undefeated. , 1997, The New England journal of medicine.

[27]  W C Black,et al.  Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. , 1993, The New England journal of medicine.

[28]  B. Hancock,et al.  Improving Survival of Patients With Hodgkin Lymphoma Over 4 Decades: Experience of the British National Lymphoma Investigation (BNLI) With 6834 Patients , 2017, Clinical lymphoma, myeloma & leukemia.

[29]  Amy P Abernethy,et al.  Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  W. Haenszel,et al.  The first fifty years of the Connecticut Tumor Registry: reminiscences and prospects. , 1986, The Yale journal of biology and medicine.

[31]  H. Welch,et al.  Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors , 2018, Annals of Internal Medicine.

[32]  H. Welch,et al.  Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics. , 2015, The New England journal of medicine.